The U.S. nebulizer market size is anticipated to reach
USD 435.5 million by 2025, according to a new report by Grand View Research,
Inc., expanding at a 6.2% CAGR during the forecast period. Rising incidence of
chronic respiratory diseases in U.S., increasing demand for home healthcare
devices, and growing geriatric population are among the key factors driving
market growth.
Rising incidence of chronic respiratory
diseases is a crucial driver for market growth. According to statistics
published by the Centers for Disease Control and Prevention (CDC),
approximately 18.4 million adults in U.S. suffer from asthma. Chronic
obstructive pulmonary disease (COPD) was estimated to be the third leading
cause of death in the country in 2014, according to the CDC, with around 15.7
million Americans diagnosed with the condition that year. Factors such as
overconsumption of tobacco and alcohol, unhealthy diet, lack of physical activity,
and alarming rates of obesity are also likely to lead to an increase in
incidence of respiratory disorders in U.S., contributing to the growth of the
nebulizer market over the forecast period.
Home healthcare devices have been
gaining popularity and market share in recent years. Growing geriatric
population in U.S., high incidence of target diseases, and rising need to curb
healthcare expenditure are expected to be some of the high-impact rendering
drivers for home healthcare devices. Home healthcare is a cost-effective
alternative to expensive hospital stays. Easy availability of compact
nebulizers ideal for home use and technological innovations in nebulizers to
reduce noise and improve functionality are increasing their adoption in home
healthcare. Moreover, third-party payers, such as insurance companies, favor
such devices as they aim to reduce costs while providing quality healthcare
services. Such factors are also expected to contribute to market growth.
Browse full research report on U.S. Nebulizer Market: https://www.grandviewresearch.com/industry-analysis/us-nebulizer-market
Further key findings from the study suggest:
- Pneumatic nebulizer accounted for the largest share, by
product, in 2016. Factors such as high prevalence of respiratory disorders
in aging population have contributed to the dominant share commanded by
these devices
- Mesh nebulizer is anticipated to be the fastest growing
segment over the forecast period. Technological advancements in these
devices will propel growth
- Major players in the market include Omron Corporation;
Koninklijke Philips N.V.; PARI Pharma; Allied Healthcare Products, Inc.;
Becton, Dickinson and Company; Agilent Technologies; Medline Industries,
Inc.; Briggs Healthcare; Drive Medical; and GF Health Products, Inc.
Browse
request sample of this report by Grand View Research: https://www.grandviewresearch.com/industry-analysis/us-nebulizer-market/request/rs1
Grand View Research has segmented the U.S. nebulizer market on the
basis of product and region:
Nebulizer Product Outlook (Revenue, USD Million, 2014 - 2025)
- Pneumatic
- Standalone
- Portable
- Ultrasonic
- Standalone
- Portable
- Mesh
Nebulizer Product Outlook (Volume, Units Sold, 2014 - 2025)
- Pneumatic
- Standalone
- Portable
- Ultrasonic
- Standalone
- Portable
- Mesh
About
Grand View Research
Grand View Research, Inc. is a U.S.
based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated
research reports, customized research reports, and consulting services. To help
clients make informed business decisions, we offer market intelligence studies
ensuring relevant and fact-based research across a range of industries, from
technology to chemicals, materials and healthcare.
No comments:
Post a Comment